Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

Documenti analoghi

• Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
  di: Ulhaq, Zulvikar Syambani, et al.
  Pubblicazione: (2020)
• The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis
  di: Ulhaq, Zulvikar Syambani, et al.
  Pubblicazione: (2020)
• Interleukin-6 as a potential biomarker of COVID-19 progression
  di: Ulhaq, Zulvikar Syambani, et al.
  Pubblicazione: (2020)
• Interleukin-6 levels in children developing SARS-CoV-2 infection
  di: Soraya, Gita Vita, et al.
  Pubblicazione: (2020)
• The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
  di: Ulhaq, Zulvikar Syambani, et al.
  Pubblicazione: (2020)